CVL-354

· Cerevel Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CVL-354, covering 2024-11-26 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing [Phase 1]

See pricing